Search Results

There are 70609 results for: content related to: Leucine-rich repeat kinase 2 ( LRRK2 ) mutations in a Swedish Parkinson cohort and a healthy nonagenarian

  1. You have full text access to this OnlineOpen article
    Cellular processes associated with LRRK2 function and dysfunction

    The FEBS Journal

    Volume 282, Issue 15, August 2015, Pages: 2806–2826, Rebecca Wallings, Claudia Manzoni and Rina Bandopadhyay

    Version of Record online : 9 MAY 2015, DOI: 10.1111/febs.13305

  2. You have free access to this content
    Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER–Golgi export

    The EMBO Journal

    Volume 33, Issue 20, 16 October 2014, Pages: 2314–2331, Hyun Jin Cho, Jia Yu, Chengsong Xie, Parvathi Rudrabhatla, Xi Chen, Junbing Wu, Loukia Parisiadou, Guoxiang Liu, Lixin Sun, Bo Ma, Jinhui Ding, Zhihua Liu and Huaibin Cai

    Version of Record online : 8 SEP 2014, DOI: 10.15252/embj.201487807

  3. You have free access to this content
    Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein

    Journal of Neurochemistry

    Volume 122, Issue 3, August 2012, Pages: 650–658, Jingwen Niu, Mei Yu, Chunyan Wang and Zhiheng Xu

    Version of Record online : 22 JUN 2012, DOI: 10.1111/j.1471-4159.2012.07809.x

  4. You have full text access to this OnlineOpen article
    Novel recruitment strategy to enrich for LRRK2 mutation carriers

    Molecular Genetics & Genomic Medicine

    Volume 3, Issue 5, September 2015, Pages: 404–412, Tatiana Foroud, Danielle Smith, Jacqueline Jackson, Jennifer Verbrugge, Cheryl Halter, Leah Wetherill, Katherine Sims, Winnie Xin, Vanessa Arnedo, Shirley Lasch, Kenneth Marek and the Parkinson's Progression Markers Initiative

    Version of Record online : 6 MAY 2015, DOI: 10.1002/mgg3.151

  5. You have free access to this content
    Abstracts

    Movement Disorders

    Volume 32, Issue S2, June 2017, Pages: S1–S627,

    Version of Record online : 2 JUN 2017, DOI: 10.1002/mds.27087

  6. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  7. Prediction of the Repeat Domain Structures and Impact of Parkinsonism-Associated Variations on Structure and Function of all Functional Domains of Leucine-Rich Repeat Kinase 2 (LRRK2)

    Human Mutation

    Volume 35, Issue 4, April 2014, Pages: 395–412, Ryan D. Mills, Terrence D. Mulhern, Fei Liu, Janetta G. Culvenor and Heung-Chin Cheng

    Version of Record online : 24 FEB 2014, DOI: 10.1002/humu.22515

  8. Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease

    Movement Disorders

    Volume 31, Issue 8, August 2016, Pages: 1192–1202, Connie Marras, Roy N. Alcalay, Chelsea Caspell-Garcia, Christopher Coffey, Piu Chan, John E. Duda, Maurizio F. Facheris, Rubén Fernández-Santiago, Javier Ruíz-Martínez, Tiago Mestre, Rachel Saunders-Pullman, Claustre Pont-Sunyer, Eduardo Tolosa, Bjorg Waro and the LRRK2 Cohort Consortium

    Version of Record online : 19 APR 2016, DOI: 10.1002/mds.26614

  9. Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications

    Movement Disorders

    Volume 26, Issue 8, July 2011, Pages: 1386–1397, Zhenyu Yue and M. Lenard Lachenmayer

    Version of Record online : 29 APR 2011, DOI: 10.1002/mds.23737

  10. Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry

    Movement Disorders

    Volume 32, Issue 10, October 2017, Pages: 1432–1438, Annie J. Lee, Yuanjia Wang, Roy N. Alcalay, Helen Mejia-Santana, Rachel Saunders-Pullman, Susan Bressman, Jean-Christophe Corvol, Alexis Brice, Suzanne Lesage, Graziella Mangone, Eduardo Tolosa, Claustre Pont-Sunyer, Dolores Vilas, Birgitt Schüle, Farah Kausar, Tatiana Foroud, Daniela Berg, Kathrin Brockmann, Stefano Goldwurm, Chiara Siri, Rosanna Asselta, Javier Ruiz-Martinez, Elisabet Mondragón, Connie Marras, Taneera Ghate, Nir Giladi, Anat Mirelman, Karen Marder and for the Michael J. Fox LRRK2 Cohort Consortium

    Version of Record online : 22 JUN 2017, DOI: 10.1002/mds.27059

  11. Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 889–897, Nicolas Dzamko, Dominic B. Rowe and Glenda M. Halliday

    Version of Record online : 25 FEB 2016, DOI: 10.1002/mds.26529

  12. Physiologically relevant factors influence tau phosphorylation by leucine-rich repeat kinase 2

    Journal of Neuroscience Research

    Volume 93, Issue 10, October 2015, Pages: 1567–1580, Matthew Hamm, Rachel Bailey, Gerry Shaw, Shu-Hui Yen, Jada Lewis and Benoit I. Giasson

    Version of Record online : 30 JUN 2015, DOI: 10.1002/jnr.23614

  13. Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease

    Movement Disorders

    Volume 27, Issue 8, July 2012, Pages: 1004–1011, David A. Elliott, Woojin S. Kim, Sarsha Gorissen, Glenda M. Halliday and John B.J. Kwok

    Version of Record online : 23 APR 2012, DOI: 10.1002/mds.25005

  14. LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2536–2541, Rachel Saunders-Pullman, Matthew J. Barrett, Kaili M. Stanley, Marta San Luciano, Vicki Shanker, Lawrence Severt, Ann Hunt, Deborah Raymond, Laurie J. Ozelius and Susan B. Bressman

    Version of Record online : 3 SEP 2010, DOI: 10.1002/mds.23314

  15. You have free access to this content
    Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β

    The FEBS Journal

    Volume 281, Issue 1, January 2014, Pages: 3–13, Fumitaka Kawakami, Naoki Shimada, Etsuro Ohta, Go Kagiya, Rei Kawashima, Tatsunori Maekawa, Hiroko Maruyama and Takafumi Ichikawa

    Version of Record online : 28 NOV 2013, DOI: 10.1111/febs.12579

  16. Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death

    Human Mutation

    Volume 32, Issue 12, December 2011, Pages: 1390–1397, Dario C. Angeles, Bong-Hwa Gan, Luisa Onstead, Yi Zhao, Kah-Leong Lim, Justus Dachsel, Heather Melrose, Matt Farrer, Zbigniew K. Wszolek, Dennis W. Dickson and Eng-King Tan

    Version of Record online : 12 SEP 2011, DOI: 10.1002/humu.21582

  17. LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study

    Neuropathology and Applied Neurobiology

    Volume 37, Issue 7, December 2011, Pages: 777–790, S. Sharma, R. Bandopadhyay, T. Lashley, A. E. M. Renton, A. E. Kingsbury, R. Kumaran, C. Kallis, C. Vilariño-Güell, S. S. O'Sullivan, A. J. Lees, T. Revesz, N. W. Wood and J. L. Holton

    Version of Record online : 27 OCT 2011, DOI: 10.1111/j.1365-2990.2011.01187.x

  18. You have free access to this content
    LRRK2 in Parkinson’s disease: in vivo models and approaches for understanding pathogenic roles

    The FEBS Journal

    Volume 276, Issue 22, November 2009, Pages: 6445–6454, Zhenyu Yue

    Version of Record online : 5 OCT 2009, DOI: 10.1111/j.1742-4658.2009.07343.x

  19. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  20. You have free access to this content
    Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment

    Journal of Neurochemistry

    Volume 111, Issue 3, November 2009, Pages: 703–715, Christian L. Klein, Giorgio Rovelli, Wolfdieter Springer, Christoph Schall, Thomas Gasser and Philipp J. Kahle

    Version of Record online : 27 AUG 2009, DOI: 10.1111/j.1471-4159.2009.06358.x